Add-on therapy: When two are not better than one

[1]  G. Cruccu,et al.  Duloxetine and pregabalin: High-dose monotherapy or their combination? The “COMBO-DN study” – a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain , 2013, PAIN®.

[2]  P. Wiffen,et al.  COMBINATION PHARMACOTHERAPY FOR THE TREATMENT OF NEUROPATHIC PAIN IN ADULTS , 2012, The Cochrane database of systematic reviews.

[3]  J. Berlin,et al.  Placebo response changes depending on the neuropathic pain syndrome: results of a systematic review and meta-analysis. , 2012, Pain medicine.

[4]  A. J. Green,et al.  Impact of type 2 diabetes mellitus on prescription medication burden and out-of-pocket healthcare expenses. , 2010, Diabetes research and clinical practice.

[5]  D. Tu,et al.  Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial , 2009, The Lancet.

[6]  M. Versavel,et al.  Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: A randomized, double‐blind study , 2008, European journal of pain.

[7]  J. Farrar,et al.  Pharmacologic management of neuropathic pain: Evidence-based recommendations , 2007, PAIN.

[8]  M. Max,et al.  Combination pharmacotherapy for neuropathic pain: current evidence and future directions , 2005, Expert review of neurotherapeutics.

[9]  R. Dworkin,et al.  NEUROPATHIC PAIN SECTION Original Research Articles Experience and Challenges Presented by a Multicenter Crossover Study of Combination Analgesic Therapy for the Treatment of Painful HIV-Associated Polyneuropathies , 2016 .

[10]  BMC Neurology BioMed Central , 2008 .